Stock TELO TELOMIR PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Telomir Pharmaceuticals, Inc.

Equities

TELO

US87975F1049

Delayed Nasdaq
Other stock markets
 14:15:22 2024-05-30 EDT 		5-day change 1st Jan Change
5.97 USD -7.15% Intraday chart for Telomir Pharmaceuticals, Inc. -5.24% 0.00%
05-13 Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C
Telomir Pharmaceuticals, Inc. Announces Resignation of Christos Nicholoudis, Esq. as the General Counsel and A Member of the Board of Directors
Telomir Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
Telomir Pharmaceuticals Presents Promising Pre-Clinical Data for Its Lead Development Product At Singapore Conference
Telomir Pharmaceuticals, Inc. has completed an IPO in the amount of $7 million.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TELO Stock
  4. News Telomir Pharmaceuticals, Inc.
  5. Other languages